Xanthus Life Sciences Changes Name to Xanthus Pharmaceuticals
News Feb 23, 2006
Xanthus Life Sciences, Inc. has announced that it has changed its corporate name to Xanthus Pharmaceuticals, Inc. The name change aligns the Company's corporate name with its strategic focus to build a differentiated specialty pharmaceuticals business.
"The last two years' efforts have focused on the development of the Company's clinical pipeline, which today includes two exciting compounds in clinical development and a third expected to enter the clinic later this year," stated Richard T. Dean, Ph.D., President and CEO of Xanthus.
"2006 will be an important building year for the Company as we develop our rapidly evolving pipeline and seek to in-license additional compounds to complement our portfolio."
"As such, we felt a change in our corporate name to Xanthus Pharmaceuticals, Inc. more appropriately describes our strategic focus."
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE